Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

Phase IIIb, Observer-blind Study to Compare Immunogenicity of GSK Biologicals' HPV-16/18 L1/AS04 Vaccine Versus GardasilĀ® [Quadrivalent Human Papillomavirus (HPV-6,11,16,18 L1 VLP) Recombinant Vaccine Merck & Co., Inc.]
Human Papillomavirus Types 16 and 18 Vaccine
108933
NCT00423046
Infections, Papillomavirus
Phase 3
 
May 2013

Powered by ideaPoint, Inc.